---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-391390"
form_type: "8-K"
ticker: "EVMN"
cik: "0002044725"
company_name: "Evommune, Inc."
filed_at: "2026-09-15T12:30:23+00:00"
generated_at: "2026-09-15T12:35:38.371770+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Evommune updates corporate presentation (Sept 2026); filing lacks extractable figures

## Summary
- Evommune (EVMN) posted an updated corporate presentation dated September 15, 2026 on its IR website.
- The furnished presentation exhibit was not included in the filing excerpt; no pipeline, financial, or guidance figures are available.
- No earnings, deal, or clinical announcements are contained in the 8-K body.
- Report signed by President and CEO Luis Peña; disclosure is routine and procedural in nature.

## SEC filing metadata
- accession: 0001193125-26-391390
- form_type: 8-K
- ticker: EVMN
- cik: 0002044725
- company_name: Evommune, Inc.
- filed_at: 2026-09-15T12:30:23+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2044725/000119312526391390/0001193125-26-391390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2044725/000119312526391390/evmn-20260915.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-391390
- JSON: https://secwatch.observer/filing/0001193125-26-391390.json
- Plain text: https://secwatch.observer/filing/0001193125-26-391390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.